This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision.
We’re thrilled to be pursuing SalA and progressing research, as we strive for new treatments.”. Importantly, Revixia’s product will be paired with a digital therapeutic being developed by atai company Introspect Digital Therapeutics, with the aim of streamlining preparation, integration, and continued patient engagement. “In
Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.
It is quite common for cannabis researchers to make use of vertebrates since animals with spines have an endocannabinoid system (ECS), such as mice and rats. Cats do have an ECS, but why use them for research*? Unfortunately, both of these conditions result in cognitive decline and suffer from a lack of effective treatment.
A team of researchers at Australia’s University of Queensland and at Botanix Pharmaceuticals Limited found, for the first time, that CBD is effective in killing Gram-negative bacteria which could mean that a new class of antibiotics can be developed for bacteria which is resistant to other forms of pharmaceutical medications. .
For conditions like anxiety and PTSD, certain strains with higher CBD content may provide calming effects without the psychoactive properties associated with THC. The endocannabinoid system and mental health How does medical marijuana affect mood disorders and other mental health conditions? The effectiveness of CBD vs.
As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. . Endometriosis is a poorly-understood condition causing severe chronic pain and alterations in a woman’s menstrual cycle. Self medicating for endometriosis. As an understudied disease, treatment is limited. Cannabinoid crystals.
Aims to support acceleration of clinical development of low-dose psilocybin in SUNHA and 5MeO-DMT in other neuro-psychiatric indications. The progress Beckley Psytech has made in attracting exceptional talent to the team and advancing our ambitious clinical development programmes over the past two years has been tremendously exciting.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
The Office of Drug Control (ODC) issues several license types, including: Cultivation growing cannabis for medicinal or research purposes. Research studying cannabis for medicinal development. Businesses should also investigate potential research and development (R&D) incentives if applicable.
Research Team to Study the Impact of CBD on Spinal Injury Pain. Professor Luke Henderson is set to be the study’s lead investigator and he explains that the unfortunate truth for more than half of spinal cord injury patients is the development of chronic pain. Dr. Carins is a postdoctoral researcher who completed her Ph.D.
However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” Although it is true that psychedelic consumers do report many psychosis-like symptoms, this can be attributed to the use of other psychoactive drugs and pre-existing or underlying mental health conditions. .
(CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ Field Trip “), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). About Field Trip Health Ltd. KCSA Strategic Communications.
Endorphins have long been connected to the runner’s high phenomenon, but new research has found that cannabinoid receptors—the very ones cannabinoids from cannabis bind to—play a key role. . The research—which summarizes nearly two decades worth of work on the matter—was conducted by Hilary Marusak and a team of other researchers.
The findings of a new study into cannabis use disorder (CUD) among veterans have been released by a team of researchers from Pennsylvania’s Center of Excellence in Substance Addiction Treatment and Education at the Corporal Michael J. Crescenz VA Medical Center. Their hypothesis was published in the American Journal of Psychiatry.
The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. appeared first on.
federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.
While many have speculated that the skunk smell could be attributed to the terpenes , or aromatic compounds, of cannabis, the research team behind the study actually discovered a whole new class of volatile sulfur compounds (VSCs) to thank for the cannabis-skunk phenomenon. Studying the Chemical Makeup of Cannabis. Super Skunk. Sour Diesel.
The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. . – July 28, 2021) – PharmaDrug Inc.
The recently proposed bipartisan bill pledges $75 million towards research into the therapeutic potential of psychedelic substances in treating post-traumatic stress disorder (PTSD). The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. In a bold and unprecedented move, U.S.
Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). Thanks to an ever increasing interest in the medical benefits of cannabis, a study was recently conducted that researched the acute effects of cannabis on the symptoms of OCD.
Scientists had published legitimate research findings showing that cannabis compounds had actually slowed tumor growth in mice. He developed a concentrated oil from the cannabis plant and decided to try it on himself. He developed a concentrated oil from the cannabis plant and decided to try it on himself. Not Rick Simpson.
million in gifts in support of several causes, including the promotion of arts, Lyme and tick-borne disease research, protection of the environment, and, in this case, psychedelics research. to advance scientific research into the potential therapeutic benefits of psychedelics for mental health and well-being.
There is little relationship between blood or saliva limits on cannabis-impaired driving and the driver’s actual impairment, and law enforcement authorities must develop new detection methods, according to the findings of a new study. They also found that even 3.5 A ‘pressing need’ for better cannabis intoxication, impairment tests.
Chronic pain —a condition that affects 50.2 New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. How Were the New Guidelines for Cannabis in Chronic Pain Developed?
The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. The psychological symptoms that develop because of the trauma affect mood, cognition, memories (both suppression and the inability to form new memories) and physical health.
If this mechanism is forced to be used repeatedly and often, the body does not properly heal or develop. Often, Post-Traumatic Stress Disorder, a debilitating and chronic illness, can develop. About 10 of every 100 women (or 10%) develop PTSD sometime in their lives compared with about 4 of every 100 men (or 4%).
Senate Bill 2543 would prohibit an employer from discriminating against a person in hiring, termination, or condition of employment based on the person’s status as a medical cannabis cardholder or a positive drug test for THC. Send a message to your lawmakers in support of ending arrests. HI resident? WV resident?
The condition, known as “long COVID” — with patients often referred to as “COVID long haulers” — is typified by a series of symptoms that linger long after someone has recovered from COVID-19, even months after they no longer test positive for the novel coronavirus. What is long COVID? episodes per month.
In Miami, Dr. Fernando Fandio-Sende researches innovative approaches to OCD treatment that have emerged, with medical marijuana integrative wellness strategies increasingly recognized as a potential therapeutic avenue worth exploring. This gives us another way to think about treating the condition.
As legalization opens new pathways for cannabis research, studies continue to expand the growing list of marijuana’s medical benefits. According to Eric Brown , lead researcher in the study at McMaster University: These findings suggest real therapeutic potential for cannabinoids as antibiotics. Medical Marijuana & MRSA.
Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .
#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. But what truly matters is how these improvements translate into real life.
A new study published in the Journal of Psychopharmacology suggests that CBD — a cannabinoid found in marijuana — improves memory and may have the potential to treat conditions such as Alzheimer’s, schizophrenia, and PTSD. Marijuana, CBD, and Memory: What the Research Says.
As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.
Published in the Journal of Clinical Psychopharmacology in September 2021, researchers concluded that CBD could lessen the psychoactive effects of THC when taken together. These conditions are aimed to control any factors that might influence the results, also known as confounding variables. CBD alters the subjective effects of THC.
As of 2020, more states allow for some type of legal cannabis use than do not, and there is growing public interest in expanding the number of medical conditions that qualify for medical marijuana approval. What Does Available Cannabis Research Tell Us? What Does Available Cannabis Research Tell Us?
In Florida, Medical Marijuana is legal and can be recommended for various conditions, including PTSD, provided the patient meets specific criteria. Cannabis research related to PTSD (post-traumatic stress disorder) is a growing field. While there is some promising research on cannabis for PTSD , the evidence is still developing.
terpenes ) may help treat a number of different skin conditions. Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Some of these have been identified as possible targets for the treatment of inflammatory skin conditions.
Introduction Attention-deficit/hyperactivity disorder (ADHD) is a complex condition that can be difficult to treat. It’s estimated that between 3% and 5% of children in the United States have ADHD, which is linked with other conditions including oppositional defiant disorder and conduct disorder.
Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.
This versatile plant, which has been both vilified and celebrated throughout history, is finally getting the recognition it deserves in various sectors, including medicine, wellness, and sustainable development. Cannabidiol (CBD), one of the many compounds found in cannabis, has been at the forefront of this revolution.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content